O F T H E N E U R O E N D O C R I N E S Y S T E M . Larry W . Swanson
, D e p t . of Biological Sciences, Hedco Neuroscience Bldg., m c 2620, Univ. of Southern Calif., Los Angeles, C A 90089-2620, U S A T h e core of t h e neuroendocrine system consists of t h e hypothalamus a n d pituitary, a n d t h e mechanisms t h a t interrelate these t w o organs. W e h a v e used this system as a model for studying t h e spatio-temporal p a t t e r n s of gene expression t h a t m a y b e involved in establishing a functional system during ttik development of t h e r a t embryo, a s well as in t h e modulation of gene expression during different functional state3 of t h e a d r~l t organism. In t h e embryo, we have examined t h e spatio-temporal p a t t e r n of expression for t h e various genes t h a t a r e involved in t h e synthesis of t h e classical anterior pituitary hormone>, a n d it. w a s found t h a t t h e r e is a n interesting compartmental r,att,ern of expression which is also characterized by distinct temporal patt e r n s of expression. In addition, we have correlated theac pat,-t e r n s with t h e p a t t e r n of expression of t w o p u t a t i v e transcription factors t h a t a r e t h o u g h t t o be involved in regulating t h e expression of growth hormone, thyrotropin releasing hormone, a n d prolactin. In t h e a d u l t r a t , i t is now becoming clear t h a t individr~al hypothalamic neurosecretory neurons can n o t only synthesize multiple neuropeptidea, b u t t h a t t h e genes regulating t h e synthesis of these neuropeptides m a y b e differentially regulated by different physiological a n d behavioral factors t h a t fall u n d e r t h e b r o a d category of stress. Classical 3p-hydroxysteroid dehydrogenase/~5-~4 isomerase (3P-HSD) deficiency is an autosomal recessive form of congenital adrenal hyperplasia (CAH). In contrast to CAH due to 21-hydroxylase and 1lp-hydroxylase deficiencies, which impair steroid formation in the adrenal cortex exclusively, classical 3P-HSD deficiency affects steroid biosynthesis in the gonads as well as in the adrenals. Classical 3P-HSD deficiency is thus characterized by varying degrees of salt-losing in newborns of both sexes, associated with pseudohermaphroditism in males, while females exhibit normal sexual differentiation or mild virilization. To elucidate the molecular basis of classical 3p-HSD deficiency exhibiting various levels of severity of symptomatology, we determined the nucleotide sequence of each of the two highly homologous 3p-HSD genes in 13 classic 3P-HSD deficient patients from 10 unrelated families previously described by us andlor by Drs M.G. Forest, U. Heinrich, T. Moshang, S. Pang, A.P. Van Seters, S.C. Wallis and M. Zachmann. The 12 point mutations characterized were all detected in the type I1 3p-HSD gene, which is the gene predominantly expressed in the adrenals and gonads. No mutation was detected in the type 136-HSD gene mainly expressed in the placenta and peripheral tissues, thus providing the basis for the well recognized intact peripheral innacrine steroidogenesis in these patients. Our findings also provide a molecular explanation for the enzymatic heterogeneity ranging from the severe salt-losing form to clinically inapparent saltwasting fonn of classical 3p-HSD deficiency.
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MOLECULAR BASIS O F CONGENITAL ADRENAL HYPERPLASIA DUE T O 3P-HYDROXYSTEROID
L3
110-HYDROXYLASEAND HYPERTENSION. P. C. White, Cornell University Medical College, New York, NY 10021, USA In humans, the CYPllBI and CYPIlB2 genes on chromosome 8q22 encode steroid 110-hydroxylase isozymes that are 93% identical in amino acid sequence. CYPlIBI is expressed at high levels in the adrenal cortex, is upregulated by ACTH and encodes an enzyme with 110-hydroxylase activity.
CYPllB2 is expressed at low levels in the normal adrenal cortex but at higher levels in aldosterone secreting tumors, is up-regulated by angiotensin I1 and encodes an enzyme with 110-and 18-hydroxylase as well 18-oxidase activities.
Thus, CYPIlBl is required for cortisol synthesis whereas CYPllB2 is required for aldosterone synthesis. Steroid lln-hydroxylase deficiency (failure to convert 11-deoxycortisol to cortisol) causes a hypertensive form of congenital adrenal hyperplasia. This autosomal recessive form of genetic hypertension presumably results from accumulation of deoxycorticosterone and related metabolites with mineralocorticoid activity. We have now characterized a total of nine mutations in CYPllBl causing this disorder. Eight are point (three causing a frameshift (othkr investigators have reported one additional frameshift mutation). We have used an in vitro transfection assay to show that all five missense mutations causing 110-hydroxylase deficiency abolish enzymatic activity. In principle, deletions of CYPllBl could be generated by unequal crossing over between CYPZZBI and the adjacent CYPIlB2 gene but no such deletions were found among the deficiency alleles in this study. Seven of the ten known mutations are clustered in exons 6 to 8, a non-random distribution within the gene (P<0.04). This may reflect the location of functionally important amino acid residues within the enzyme or an increased tendency to develop mutations within this region of the gene. Glucocorticoidsuppressible hyperaldosteronism is an autosomal dominant form of hypertension in which aldosterone synthesis is ACTH regulated and there are high levels of 18-hydroxy-and 18-oxocortisol, the latter a 170-hydroxylated analog of aldosterone. In all 16 families examined thus far by us and by others, an unequal crossover has occurred generating a chromosome with a third CYPIIB gene. This third gene is a chimera with a 5' end (including regulatory sequences) corresponding to CYPIIBZ and a 3' end corresponding to CYPIIB2 The breakpoint of the crossover is always somewhere between introns 2 and 4. In vitro expression of the corresponding chimeric cDNAs demonstrate that the chimeric enzyme retains the ability to synthesize aldosterone only if the last five or more (out of nine) exons correspond to CYPIIB2. Thus, glucocorticoid-suppressible hyperaldosteronism is caused by abnormal expression and regulation of an enzyme with the ability to synthesize aldosterone from deoxycorticosterone. The observed distr~hution of breakpoints apparently reflects functional constraints on enzymatic activ~ty.
It is not yet known ~f abnormal regulation of CYPllU2 is responsible for any cases of essential hypertension.
STEROID 5a-REDUCTASE TYPE 2 DEFICIENCY.
David W.
R u s s e l l , D e p a r t m e n t o f M o l e c u l a r G e n e t i c s , UT S o u t h w e s t e r n M e d i c a l C e n t e r , D a l l a s , TX 75235, USA The enzyme 5 a -r e d u c t a s e c o n v e r t s t e s t o s t e r o n e t o d i h y d r o t e s t o s t e r o n e a n d is r e q u i r e d f o r m a l e p h e n o t y p i c s e x u a l d i f f e r e n t i a t i o n . T h e r e a r e t w o 5 a -r e d u c t a s e g e n e s i n man t h a t e n c o d e i s o z y m e s ( d e s i g n a t e d t y p e s 1 a n d 2 ) w i t h d i s t i n c t b i o c h e m i c a l a n d p h a r m a c o l o g i c a l p r o p e r t i e s a n d t i s s u e d i s t r i b u t i o n s . M u t a t i o n s i n t h e g e n e e n c o d i n g t h e t y p e 2 i s o z y m e c a u s e m a l e p s e u d o h e r m a p h r o d i t i s m .
The c h a r a c t e r i z a t i o n o f 27 m u t a t i o n s a t t h e m o l e c u l a r a n d b i o c h e m i c a l l e v e l s h a s r e v e a l e d amino a c i d s i n t h e p r o t e i n t h a t p a r t i c i p a t e i n s u b s t r a t e a n d c o f a c t o r (NADPH) b i n d i n g , a s w e l l a s d e t e r m i n a n t s o f p r o t e i n s t a b i l i t y .
An u n e x p l a i n e d f e a t u r e o f t h i s d i s e a s e h a s b e e n t h e o c c u r r e n c e o f p a r t i a l v i r i l i z a t i o n a t p u b e r t y i n a f f e c t e d m a l e s .
D e t e r m i n a t i o n o f t h e d e v e l o p m e n t a l e x p r e s s i o n p a t t e r n s o f t h e t w o 5 a -r e d u c t a s e i s o z y m e s by i m m u n o b l o t t i n g s u g g e s t t h a t t h e o b s e r v e d v i r i l i z a t i o n may be c a u s e d by e x p r e s s i o n o f t h e t y p e 1 i s o z y m e i n t h e l i v e r a n d s k i n . T h i s r e s u l t s u g g e s t s t h a t d i h y d r o t e s t o s t e r o n e may a c t i n a t r u e e n d o c r i n e f a s h i o n i n a d d i t i o n t o t h e a u t o c r i n e a n d p a r a c r i n e mechanisms t y p i c a l l y a s c r i b e d t o t h i s a n d r o g e n .
Transmembrane Signalling Diseases . The McCune Albright syndrome (MAS) is a sporadic disorder with pleiotropic manifestations including autonomous endocrine hyperfunction, polyostotic fibrous dysplasia, and cafe-au-laif skin pigmentation. Since the endocrine abnormalities in MAS (e.g. gonadotropin-independent precocious puberty, growth hormone hypersecretion, hyperthyroidism, hypercortisolism) are all consistent with constitutive activation of the c A M P 2nd messenger system, we screened tissues from patients with M A S for mutations in the G protein a subunit (Gs-a) that regulates cAMP formation. W e found missense mutations that lead to constitutive activation of Gs-u (either Arg 201-> His or Arg 201-> Cys) in affected endocrine tissues from all subjects with MAS studied. The mutations were found in a mosaic distribution consistent with a somatic mutation occurring early in embryogenesis. G s -a mutations were also found in dysplastic bone samples, and in various nonendocrine tissues such as liver and heart. Mutations in the latter may be responsible for previously Gs-a as the cause of most if not all of the manifestations c a u s e s a n d have pointed to cellular pathways that arc important for the maintenance of glucose homeostasis and whose pcaurbation may conlrihutc to the o f M A S h a s i m p o r t a n t i m p l i c a t i o n s f o r o u r u n d e r s t a n d i n g o f cAM1' dcvclonmcnt of the morc common lac-onset forms of NIDDM. r e g u l a t i o n o f c e l l f u n c t i o n , a n d ultinlately, f o r t r e a t m e n t o f M A S .
G R O W T H H O R M O N E INSENSITIVITY S Y
Howard Hughes Medical Instituu: and Dcpartmenu of Gcnet~cs and Pediatrics.
Stanford University, Stanford, CA 94305, USA Growth hormone inscnsilivity syndrome (CHIS or Laron syndrome) is an aulosomal recessive disorder caused by mutations in rhc gene for the growth hormone receptor (GHR). This genc, located on chromosome region 5p13.1-p12 ( I ) encodes a 6 2 0 amino acid protcin with a ccntrally located hydrophobic transmembrane d o m a~n .
Proteolytic cleavage of the cxtracellular domain that includes the growth hormone bind~ng s~t e gcncratcs the circulating GHBP. One G H molecule binds to two GHBP molecule resulting in dimcrizat~on of the receptors, possibly an esscntlal step for signal transduct~on.
In order to detect GHR mut;~tions In p;~ticnts wtth C H I S , a screening procedure has been devised (2.3). All nlnc cxons and s u r r o u n d~n g splice junctions of the G H R gene are amplifted by PCR w~t h p r~m c r s d c s~g n c d from the published sequence. Each PCR product IS analysed for altered ~nelting behavior by denaturing gradient gel clcctrophoresis (DGGE). A GC-clamp is added to one primer to ensurc complete analys~s 01' the cntlrc exon and splice site regions. PCR products that arc positlvc by DGGE scrccnlng arc sequenced either directly or after subcloning. In our laboratory, Dr. Mary Anne Berg has identified two nonsense mutations (R43X arid R217X). two splice lunction mutations (189-1 G-to-T and 71+1 G-to-A) and two l'rameshift mutations leading to translational stop codons (46 dcl TT and 230 del T A ) all of which involve either exon 4 or exon 7 (3). The niost t~nusual mutation -that she has detected in over 5 0 affectcd ~ndividuals from Ecuador -involves a single nucleotide substitution in codon I80 that doca not change the amino acid encoded (EISOE). Thc A-to-G transvcrslon, however, creates a new 5' spllcc site which is exclusively uscd and lcads to am in-frame dcletion 01 24 nucleotidcs from exon 6 in the patients' niRNA (2). Since the G H b~n d l n g and rcccptor dimerizat~on sites would rernaln intact hut no response to G H has hccn rcportcd in these paticnts, the mutant rcccptor protcln is poalulatcd to undergo abnornial folding and intracellular dcgradatlon. The EIXOspIlcc mutation has not been derected in any pattents outside of Ecuador
In general, the mutations arc unique to parttculatr l a n i~l~c s or gcograph~c areas. Only R43X has recurred on d~ilcrent haplotype hackgrounds. 
M O L E C U L A R G E N E T I C S O F E A R L Y -O N S E T N O N -I N S U L I N -DEPENDENT (TYPE 2) DIABETES MELLITUS. G.I., Howard tlughcs
Medical Institute, University of Chicago, Chicago, 1L 60637, USA NIDDM is one of the most common metabolic diseases affecting -5% of the world population. Howcvcr despite much research, the genetic and nongcnetic I'ac~ors that conlrihuu: to its dcvelopmcnt rcmllin largely unknown. Careful clinical studies of subjects with NIDDM whose onset occurred during childhood or adolcsccncc havc idcntilicd a Familial form of diabctes termed maturity-onset diabetes of the young or MODY. Its carly age of onsct, autosomal dominant mode of inheritance and availability of multigenerational pcdigrces make MODY an attractive model for identifying diabctcs-susceptibility genes using gcnctlc Fetal growth (FG) in late gestation (LG) is primarily determined by uteroplacental transfer of nutrients. FG is normally constrained by the capacity of this transfer. In LG, fetal IGF-I is acutely regulated by glucose, but not by amino acid availabtltty, acting via enhanced insulin release; this provides the mechanism of fetal overgrowth induced by hyperinsulinism. Fetal IGF-I levels correlate with fetal nutritional status and thus FG. Direct evidence for the role of IGF-1 in FG is provided by embryo transfer experiments in mice selected for high or low IGF-l levels. The infusion of IGF-I (60~glkglhr) to LG fetal sheep increased IGF-I 4 fold without a measurable change in fetal or placental glucose uptake. However placental lactate production fell (~1 0 . 0 3 ) . The amino-nitrogen concentration fell (p <0.01) in both mother and fetus as did fetal urea production (J <0.05). These observations suggest that IGF-I inhihits fetal protein catabolism, promotes fetal anabolism, enhances placental amino acid transfer and alters placental metabolism favourably. It is suggested that glucose availability affects tetal IGF-I production via altered insulin secretion and this in turn has anabolic and anticatabolic consequences. IGF binding proteins are also acutely modulated hy nutrient availability. Fetal IGF-2 in late gestation is under lesser nutritional regulation compatible with a more constitutive role in the regulation of FG. Maternal IGF-l administration throughout pregnancy in rodents abolishes the physiological constrilints on FG without affecting placental growth. Maternal IGF-I administration reduces fetal urea production in sheep. It is suggestd that maternal IGF-1,under nutr~tion;~l and hormonal control.determines nutrient availability and transfer across the placenta Thus optimal FG depends on coordinate increases in both feral and maternal IGF-I 
